Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Murat, Ozbalak"'
Autor:
Simge ERDEM, Metban MASTANZADE, Mustafa Murat OZBALAK, Dilek Ozden OZLUK, Tarık Onur TIRYAKI, Beyza OLUK, Ipek YONAL HINDILERDEN, Mustafa Nuri YENEREL, Meliha NALCACI, Sevgi KALAYOGLU BESISIK, Sevda SERT EKINCI, Tufan TUKEK
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S52- (2021)
Objective: Patients with cancer are considered highly vulnerable to the COVID-19 disease. However, there are still few data in hematologic patients. Some small studies have shown a high mortality on patients with hematologic malignancies and COVID-19
Externí odkaz:
https://doaj.org/article/46923d1fb2504c958a9c7ce3a16c01f9
Autor:
Elif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, Muhit Ozcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Fergun Yilmaz, Derya Koyun, Nihan Alkis, Inci Alacacioglu, Mehmet Sonmez, Irfan Yavasoglu, Anil Tombak, Ozgur Mehtap, Fatih Kurnaz, Orhan Kemal Yuce, Volkan Karakus, Mehmet Turgut, Derya Deniz Kurekci, Mesut Ayer, Muzaffer Keklik, Deram Buyuktas, Murat Ozbalak, Burhan Ferhanoglu
Glofitamab is a CD3xCD20 bi-specific antibody with two fragments directed to the CD20 antigen and a single CD3-binding fragment. Encouraging response and survival rates were recently reported in a pivotal phase II expansion trial conducted in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2497f4e81be510fd6626ab724fb52159
https://hdl.handle.net/11424/289907
https://hdl.handle.net/11424/289907
Autor:
Metin Yusuf Gelmez, Fatma Betul Oktelik, Suzan Cinar, Murat Ozbalak, Ozden Ozluk, Melih Aktan, Gunnur Deniz
Publikováno v:
Journal of Hematopathology. 15:117-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c843cbdb5030cc514f46612e50b722
https://doi.org/10.1007/s12308-022-00497-5
https://doi.org/10.1007/s12308-022-00497-5
Autor:
Ezgi Pınar Özbalak, Sevgi Kalayoglu Besisik, Tarık Onur Tiryaki, Ali Yilmaz Altay, Metban Mastanzade, Murat Ozbalak, Özden Özlük, Gulcin Yegen, Ipek Yonal-Hindilerden, Mustafa Nuri Yenerel, Meliha Nalcaci
Publikováno v:
İstanbul Kanuni Sultan Süleyman Tıp Dergisi. 13:194-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc166e085df245c323d653a464fbd7fb
https://doi.org/10.4274/iksstd.2021.35761
https://doi.org/10.4274/iksstd.2021.35761
Publikováno v:
Case Reports in Pulmonology, Vol 2017 (2017)
Bronchus Associated Lymphoid Tissue Lymphoma (BALTOMA) is a rare subgroup of pulmonary non-Hodgkin’s lymphomas (NHLs) comprising less than 1% of all cases. It constitutes 3.6% of all extranodal lymphomas and only 0.5–1% of primary pulmonary malig
Externí odkaz:
https://doaj.org/article/e1f6c583a87e433585555fe35167280b
Autor:
Sevgi, Kalayoglu Besisik, Murat, Ozbalak, Yavuz Burak, Tor, Alpay, Medetalibeyoglu, Murat, Kose, Naci, Senkal, Atahan, Cagatay, Mustafa, Erelel, Ahmet, Gul, Figen, Esen, Serap, Simsek Yavuz, Haluk, Eraksoy, Tufan, Tukek
Publikováno v:
Am J Blood Res
Objective: Severe acute respiratory syndrome (SARS) coronavirus 2 (SaRS-Cov-2) associated respiratory disease (COVID-19), announced as a pandemic, is a multisystem syndrome. SARS-CoV-2 directly infects and damages vascular endothelial cells, which le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::057b19bbc2f2f6cbbda3ff4b87ae43ae
https://pubmed.ncbi.nlm.nih.gov/35603126
https://pubmed.ncbi.nlm.nih.gov/35603126
Autor:
Teoman Soysal, Semra Paydas, Nuri Karadurmus, Elif Birtas, Murat Ozbalak, Hakan Goker, Birol Yildiz, Vildan Ozkocaman, Muhit Ozcan, Pervin Topcuoglu, Ayse Salihoglu, Burhan Ferhanoglu, Evren Ozdemir, Münci Yağcı, Leylagül Kaynar, Ihsan Karadogan
Publikováno v:
Annals of Hematology. 99:301-307
Classical Hodgkin lymphoma (cHL) is considered a curable disease; however, approximately one-third of responders experience disease relapse following first-line therapy. Several studies have shown the efficacy of brentuximab vedotin (BV) in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6aea850b32809621c52214b62a20362
https://doi.org/10.1007/s00277-019-03899-1
https://doi.org/10.1007/s00277-019-03899-1
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S33-(2021)
Objective Asparaginase has a very important role in ALL treatment among increasing of remission rate and duration. Multiple side effects prevent its regulatory use. Asparaginase reduce antithrombin 3, heparin cofactor II, protein C and plasminogen sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e79f030157e7c2ee76d22504dd376a8
http://www.sciencedirect.com/science/article/pii/S2531137921011585
http://www.sciencedirect.com/science/article/pii/S2531137921011585
Autor:
Hasan Sami Goksoy, Sevgi Kalayoglu Besisik, Zübeyde Nur Özkurt, Mehmet Sönmez, Sinem Civriz Bozdag, Irfan Yavasoglu, Tugrul Elverdi, Özgür Mehtap, Orhan Ayyildiz, Ahmet Kursad Gunes, Meliha Nalcaci, Burhan Ferhanoglu, Sebnem Izmir Guner, Meltem Kurt Yuksel, Elif Birtas Atesoglu, Selami Kocak Toprak, Tuğçe Nur Yiğenoğlu, Mustafa Pehlivan, Birol Yildiz, Ozan Salim, Rahsan Yildirim, Tayfur Toptas, Leylagül Kaynar, Ant Uzay, Murat Albayrak, Gülsüm Özet, Güray Saydam, Murat Ozbalak, Fevzi Altuntaş, İpek Yönal Hindilerden, Meltem Ayli, Olga Meltem Akay, Mehmet Hilmi Dogu
Publikováno v:
Web of Science
The AETHERA trial reported an increased progression-free survival (PFS) when brentuximab vedotin (BV) was used as maintenance therapy in high-risk Hodgkin lymphoma (HL) after autologous stem cell transplantation (ASCT). Thus, we aimed to determine th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a7c1c4c72fda6e1343d54d2a49939b
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
Autor:
null Olga Meltem Akay, null Murat Ozbalak, null Mustafa Pehlivan, null Birol Yildiz, null Ant Uzay, null Tugce Nur Yigenoglu, null Tugrul Elverdi, null Leylagul Kaynar, null Orhan Ayyildiz, null Ipek Yonal Hindilerden, null Hasan Sami Goksoy, null Sebnem Izmir Guner, null Ahmet Kursad Gunes, null Mehmet Sonmez, null Meltem Kurt Yuksel, null Sinem Civriz Bozdag, null Zubeyde Nur Ozkurt, null Tayfur Toptas, null Mehmet Hilmi Dogu, null Ozan Salim, null Guray Saydam, null Irfan Yavasoglu, null Meltem Ayli, null Gulsum Ozet, null Murat Albayrak, null Elif Birtas Atesoglu, null Selami K. Toprak, null Rahsan Yildirim, null Ozgur Mehtap, null Sevgi Kalayoglu Besisik, null Meliha Nalcaci, null Fevzi Altuntas, null Burhan Ferhanoglu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a169dfe3149b0b8d46caf5c1faf24b5a
https://doi.org/10.1002/hon.2897/v2/response1
https://doi.org/10.1002/hon.2897/v2/response1